Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Seattle, Washington 98109


The purposes of this are: - To determine the highest doses of Taxol and Navelbine that we can safely give to patients; - To determine what kind of side effects are caused by the combination of Taxol, Navelbine and G-CSF; - To determine whether the combination of Taxol, Navelbine and G-CSF is more effective than standard therapy in treating metastatic breast cancer and prolonging life;


INCLUSION To be eligible, volunteers must: - Have stage IV carcinoma of the breast that has been microscopically confirmed - Be age > 18 - Be fully active or ambulatory with symptoms but able to do light work - Have a life expectancy of > 16 weeks - Be > 2 weeks from prior surgery; > 3 weeks from radiation therapy to the pelvis, spine or long bones; > 3 weeks from prior chemotherapy (> 6 weeks for mitomycin C or nitrosureas) and > 2 weeks from prior hormonal therapy - Have had one or less prior regimens for metastatic disease - Have measurable (bidimensionally) or evaluable disease that is in an area that has not been radiated EXCLUSION Patients are not eligible if they: - Have rapidly progressing liver or lung metastases or uncontrolled central nervous system metastases - Are medically unstable - Are pregnant, nursing or unwilling to employ adequate contraception - Have pre-existing clinically significant peripheral neuropathy except for abnormalities due to cancer - Have psychological, familial, sociological or geographical conditions that do not permit weekly medical follow-up and compliance with the study protocol - Have hypersensitivity to E. Coli-derived proteins, Filgrastim, or any of its components - Have had prior therapy with Navelbine



Primary Contact:

Principal Investigator
Julie R. Gralow, M.D.
University of Washington

Backup Contact:


Location Contact:

Seattle, Washington 98109
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.